Effect of ultrasound-guided genicular nerve neurolysis versus sham procedure on pain in patients with knee osteoarthritis: a randomized clinical trial
Open Access
- 24 June 2025
- journal article
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 27 (1) , 33-42
Abstract
Importance: Knee osteoarthritis (OA) is a prevalent and disabling condition, especially in older adults. For patients who are not candidates for total knee arthroplasty (TKA) due to comorbidities or limited access to care, minimally invasive pain-relief options are critically needed. Objective: To assess the efficacy and safety of ultrasound-guided chemical neurolysis using 95% ethanol targeting four genicular nerves in patients with symptomatic knee OA who have not responded to conservative management. Design: Double-blind, randomized, sham-controlled clinical trial. Participants: A total of 100 adults with symptomatic knee OA, confirmed radiographically and unresponsive to conservative treatment, were enrolled and randomized. Interventions: Patients were randomized to receive ultrasound-guided chemical neurolysis of the superomedial, superolateral, recurrent tibial, and inferomedial genicular nerves with 95% ethanol (treatment group) or a sham procedure (control group). Main Outcomes and Measures: The primary outcome was pain intensity measured by the Numerical Rating Scale (NRS) at 7 days, 30 days, 3 months, and 6 months post-procedure. Secondary outcomes included opioid consumption and health-related quality of life measured by the EQ-5D-5L questionnaire. Safety outcomes focused on the occurrence of neurological complications. Analyses were conducted using an intention-to-treat approach with appropriate handling of missing data. Results: Patients in the ethanol neurolysis group experienced significantly greater reductions in NRS scores at all follow-up points compared to the sham group (P < .0001). Opioid consumption was also significantly reduced in the neurolysis group throughout the 6-month period (P < .0001). Quality of life, as assessed by EQ-5D-5L, improved significantly in the treatment group (P < .0001). No neurological deficits or serious adverse events were reported in either group. Conclusions and Relevance: Ultrasound-guided chemical neurolysis of the SMGN, SLGN, RTGN, and IMGN with 95% ethanol is a safe and effective minimally invasive treatment for patients with refractory knee OA pain. It significantly reduces pain and opioid use while improving quality of life, making it a valuable therapeutic option for individuals ineligible for surgical intervention.Keywords
This publication has 40 references indexed in Scilit:
- Mediating Effect of Pain Sensitization on the Paradoxical Relation of Taking Opioids to Pain Severity in Knee Osteoarthritis: The Multicenter Osteoarthritis StudyArthritis Care & Research, 2023
- A Randomized Placebo-Controlled Trial of the Anti-Nerve Growth Factor Antibody Tanezumab in Subjects With Cancer Pain Due to Bone MetastasisThe Oncologist, 2023
- Older Age, Female Sex, Anxiety, Substance Use Disorder, Osteoarthritis, Tibial Tubercle Osteotomy, and Opioid Familiarity Are Risk Factors for Prolonged Opioid Use Following Medial Patellofemoral Ligament ReconstructionArthroscopy, Sports Medicine, and Rehabilitation, 2023
- Nerve Injury and Regeneration after Neurolysis: Ethanol Alone versus Ethanol with Brachytherapy in RabbitsJournal of Vascular and Interventional Radiology, 2022
- Genicular Nerve Radiofrequency Ablation for the Treatment of Painful Knee Osteoarthritis: Current Evidence and Future DirectionsPain Medicine, 2021
- Societal Cost of Opioid Use in Symptomatic Knee Osteoarthritis Patients in the United StatesArthritis Care & Research, 2021
- Diagnosis and Treatment of Hip and Knee OsteoarthritisJAMA, 2021
- Validity of the EQ-5D-5L questionnaire among the general population of PolandQuality of Life Research, 2020
- Total Knee Arthroplasty in Patients of Advanced Age: A Look at Outcomes and ComplicationsThe Journal of Knee Surgery, 2018
- Comparing Patient Outcomes After THA and TKA: Is There a Difference?Clinical Orthopaedics and Related Research, 2009